Table 4.
Oligonucleotide primers used in this study.
Fragment | Name | Sequence | Length (pb) |
---|---|---|---|
a | DgNF4 DegenR5 SVGCF1 SVGCR1 |
AGHTTGTTCCGWCCBTTYAC GCTCGYACTACCCTRAAYGTTCT AGTTTGTTCCGTCCCTTCAC AGCCTCAACACCCTAAATGTTCT |
620 |
b | DegenF7 DgNR9 SVGCF2 |
AATCAGCIGTAAAGTIATGGC HGCYTCHCGHADNGCYTCYT AATCAGCAGTGAAGGTGATGGC |
1610 |
c | DegenF9 SZ4 ( * ) SVGCF3 SZ3 ( * ) |
GGCCATTGTYGCCATGTCDTA CTTGAAGATCCAAAGTTGCTC GCCATTGTCGCCATGTCGTACGA GAGCGGACAAACTTGAAGATC |
1610 |
d |
SZ1
(
*
)
SZ2 ( * ) SVGCR2 |
ACCCTGAACTTATTGATATCC
TGAACTTATTGATATCC AACCAAATATAATAAAGAATACGAAG |
2000 |
e | DegenF2 DegenR3 SVGCF4 SVGCR3 |
CCITTYTGGCARGGITGG TACATRTCRTARTCRTCRTC CCTTTCTGGCAAGGCTGG TACATATCGTAATCGTCGTC |
2020 |
f | DegenF4 SZend R1 SVGCF5 |
GGITGGATHCARATHATGAA GACATCCGCTGATCGTGAG GGATGGATTCAAATTATGAA |
1650 |
*From Araujo, et al.27; Specific primers are in italic.